JANET HELLIWELL: Open Payments
NPI 1053612309 · LONGMEADOW, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 42 payments from 11 companies in 2025. Trend: 2023 $1,001 · 2024 $2,264 · 2025 $987
Food & beverage: $843Education: $144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $221 |
| Lilly USA, LLC | 7 | $149 |
| Novo Nordisk Inc | 4 | $140 |
| Astellas Pharma US Inc | 2 | $118 |
| Axsome Therapeutics, Inc. | 3 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Exact Sciences Corporation | 2 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Abbott Laboratories | 1 | $24 |
Products named: Ozempic, VRAYLAR, Auvelity, KISUNLA, JARDIANCE, UBRELVY, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across MA — which companies pay providers there.
